 |
Your Future in Pharmacy: Attend an Ownership Workshop
You need the right tools to run a stronger business and be a better owner to survive and thrive in today's highly competitive health care marketplace. This proven program is ideal both for those thinking about buying their first pharmacy or opening another. Register now for a 2012 Pharmacy Ownership Workshop, sponsored by McKesson and in part by Pharmacists Mutual. Find out what it takes to own and operate a successful pharmacy. The first workshop is scheduled for Feb. 24-26 in Dallas. Seating is limited to ensure a high degree of personalized learning and interaction. Click here to register. |
 |
Drugs and Treatment
Formulary Wins For NovoLog and NovoLog Mix 70/30
Return to Headlines
Evidence-Based Drug Policies Possible
MedPage Today (01/06/12) Fiore, Kristina
A report in a special issue of The Lancet focused on addiction, drug control, and intervention practices. Lead by John Strang, MD of Kin's College London, the researchers noted that read more...
Return to Headlines
FDA Approves Merck’s ISENTRESS for Use in Children Ages Two Years and Older as Part of HIV-1 Combination Therapy
Merck Press Release (01/06/12)
Merck has announced that the FDA recently approved the use of ISENTRESS (raltegravir) in combination with other antiretroviral (ARV) medicines, for the treatment of read more...
Return to Headlines
FDA Warns of Opioid Drug Mix-Up
MedPage Today (01/09/12) Petrochko, Cole
The FDA has issued a warning that pills, tablets, or caplets of Percocet and eight other opioid products packaged by Novartis for Endo Pharmaceuticals may have been mixed up, with one drug being read more...
Return to Headlines
Glaxo to File Advair Replacement Relovair in Mid-2012
Dow Jones Newswires (01/09/12) Stovall, Sten
GlaxoSmithKline and U.S.-based partner Theravance said they plan to submit their key new lung drug Relovair for regulatory approval in mid-2012 following encouraging late-stage trial results. The convenience of read more...
Return to Headlines
Study Finds Risk in New Stroke Drug
Wall Street Journal (01/10/12) Dooren, Jennifer Corbett
Pradaxa, the first drug to gain approval as part of a new generation of blood thinners to lower stroke risk, was associated with an increased risk of heart attack in a new study published online in read more...
Return to Headlines
|
|
|
Industry News
Drug Reps Soften Their Sales Pitches
Wall Street Journal (01/10/12) Rockoff, Jonathon D.
Pharmaceutical companies are changing the way that they market their products to physicians. Sales reps are being told by their companies, including GlaxoSmithKline, Eli Lily and Merck, to move away from read more...
Return to Headlines
Endo Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Facility
Endo Pharmaceuticals Press Release (01/09/12)
Endo Pharmaceuticals has announced that, as a result of a temporary shut-down of Novartis Consumer Health's Lincoln, Neb., manufacturing facility, there will be a short-term supply constraint of read more...
Return to Headlines
Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
Endo Pharmaceuticals Press Release (01/06/12)
Endo Pharmaceuticals has announced that it has signed a worldwide license and development agreement with U.S.-based BioDelivery Sciences International for BEMA Buprenorphine, which is currently in read more...
Return to Headlines
Xenon in $646 million Deal With Roche Unit
thepharmaletter.com (01/10/2012)
Canada-based Xenon Pharmaceuticals, a privately-owned, clinical genetics-based drug discovery and development company, has entered into a strategic alliance with Genentech to discover and develop compounds and read more...
Return to Headlines
|
|
|
Healthcare Legislation & Regulation and Medicaid/Medicare
CMS Moves Medicare Participation Deadline
American Medical News (01/09/12)
The Centers for Medicare & Medicaid Services (CMS) has extended its annual participation enrollment period through Feb. 14. CMS moved the deadline for physicians to elect to continue read more...
Return to Headlines
Colorado Partnership on Medicare Reform Rewards Doctors for Better, Cheaper Care
Denver Post (CO) (01/09/12) Booth, Michael
A platform for healthcare reform has been launched in Colorado with U.S. approval of Physician Health Partners' (PHP) accountable care organization (ACO). Colorado was one of 32 partnerships that received read more...
Return to Headlines
Medicare Names 73 Innovation Advisers
InformationWeek (01/06/2012) Versel, Neil
The Centers for Medicare and Medicaid Services (CMS) has named an initial group of 73 innovation advisers to support the Center for Medicare and Medicaid Innovation, a key element of read more...
Return to Headlines
New Law Frustrates Pharmacists: Using Database Takes Time From Helping Customers, They Say
Mountain Press (01/09/12) Farrell, Jeff
Tennessee has implemented a state law that makes it more difficult to obtain ingredients for making methamphetamine, but the new rules are frustrating some pharmacists. Under the new laws, pharmacists must read more...
Return to Headlines
|
Abstract News © Copyright 2012 INFORMATION, INC.
 |
|
|
FEATURED SPONSOR:
|
|
